TY - JOUR
T1 - Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy
AU - Maru, Duncan Smith Rohrberg
AU - Bruce, R. Douglas
AU - Walton, Mary
AU - Mezger, Jo Anne
AU - Springer, Sandra A.
AU - Shield, David
AU - Altice, Frederick L.
N1 - Funding Information:
Acknowledgments The authors would like to acknowledge the National Institutes on Drug Abuse (R01 DA13805) for funding this study as well as providing career development awards for FLA (K24 DA 0170720), SAS (K23 DA 019381-02) and RDB (K23 DA 022143). DSR receives funding from the National Institutes of Health Medical Science Training Program (GM07205). The funding sources played no role in design of the study, data collection, analysis or interpretation of results or in the writing of the report. The authors would like to thank James Taylor, Rodolfo Lopez, Angel Ojeda and Natalie Laurenco for their contribution to the study implementation. Without their active participation and attention to detail, this study would not have been possible. We additionally would like to thank Paula Dellamura for administrative support. Most importantly, we would like to thank the participants in this study who dedicated time and energy to make this research possible.
PY - 2008/3
Y1 - 2008/3
N2 - Directly administered antiretroviral therapy (DAART) can improve health outcomes among HIV-infected drug users. An understanding of the utilization of DAART-initiation, adherence, and retention-is critical to successful program design. Here, we use the Behavioral Model to assess the enabling, predisposing, and need factors impacting adherence in our randomized, controlled trial of DAART versus self-administered therapy (SAT) among 141 HIV-infected drug users. Of 88 participants randomized to DAART, 74 (84%) initiated treatment, and 51 (69%) of those who initiated were retained in the program throughout the entire six-month period. Mean adherence to directly observed visits was 73%, and the mean overall composite adherence score was 77%. These results were seen despite the finding that 75% of participants indicated that they would prefer to take their own medications. Major causes of DAART discontinuation included hospitalization, incarceration, and entry into drug-treatment programs. The presence of depression and the lack of willingness to travel greater than four blocks to receive DAART predicted time-to-discontinuation.
AB - Directly administered antiretroviral therapy (DAART) can improve health outcomes among HIV-infected drug users. An understanding of the utilization of DAART-initiation, adherence, and retention-is critical to successful program design. Here, we use the Behavioral Model to assess the enabling, predisposing, and need factors impacting adherence in our randomized, controlled trial of DAART versus self-administered therapy (SAT) among 141 HIV-infected drug users. Of 88 participants randomized to DAART, 74 (84%) initiated treatment, and 51 (69%) of those who initiated were retained in the program throughout the entire six-month period. Mean adherence to directly observed visits was 73%, and the mean overall composite adherence score was 77%. These results were seen despite the finding that 75% of participants indicated that they would prefer to take their own medications. Major causes of DAART discontinuation included hospitalization, incarceration, and entry into drug-treatment programs. The presence of depression and the lack of willingness to travel greater than four blocks to receive DAART predicted time-to-discontinuation.
KW - Acquired immunodeficiency syndrome
KW - Adherence
KW - Directly administered antiretroviral therapy
KW - Directly observed therapy
KW - HIV
KW - Substance abuse
UR - https://www.scopus.com/pages/publications/43149094466
U2 - 10.1007/s10461-007-9336-2
DO - 10.1007/s10461-007-9336-2
M3 - Article
C2 - 18085432
AN - SCOPUS:43149094466
SN - 1090-7165
VL - 12
SP - 284
EP - 293
JO - AIDS and Behavior
JF - AIDS and Behavior
IS - 2
ER -